The assessment of autofluorescence of the crystalline lens in diabetic patients and healthy controls: can it be used as a screening test?


Pehlivanoglu S., Acar N. , Albayrak S., KARAKAYA M., Ofluoglu A.

Clinical ophthalmology (Auckland, N.Z.), vol.12, pp.1163-1170, 2018 (Journal Indexed in ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 12
  • Publication Date: 2018
  • Doi Number: 10.2147/opth.s164960
  • Title of Journal : Clinical ophthalmology (Auckland, N.Z.)
  • Page Numbers: pp.1163-1170

Abstract

Background: Our purpose was to demonstrate if measuring lens autofluorescence (AF) with a scanning confocal biomicroscope may be used to identify subjects with undiagnosed type II diabetes mellitus (DM), and hence, for it to be used as a marker for the severity of diabetic retinopathy in diabetic patients.